Health and Healthcare Systems

10 things to know about malaria

A biologist puts her hand in a box with male genetically modified Aedes aegypti mosquitoes at an educational exhibition by British biotechnology company Oxitec in Piracicaba March 5, 2015. Oxitec said its laboratory created the genetically modified male Aedes aegypti mosquitoes, which are set to be released in Sao Paulo in April. A specially-made gene in the male mosquitoes seeks to reduce to number of Aedes aegypti mosquitoes by killing their offspring after mating with wild female mosquitoes. Brazil already has more than 100 000 cases of people with dengue in 2015, according to the City Department of Health.   REUTERS/Paulo Whitaker (BRAZIL - Tags: SOCIETY CRIME LAW) - RTR4S764

Some 3.2 billion people - almost half the world's population - are at risk of malaria. Image: REUTERS/Paulo Whitaker

Kieran Guilbert
Reporter, Reuters
Alex Whiting
Journalist, The Thomson Reuters Foundation
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on Health and Healthcare Systems?
The Big Picture
Explore and monitor how Health and Healthcare is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Future of Global Health and Healthcare

Efforts to end malaria, which killed an estimated 438,000 people in 2015, are under threat as mosquitoes become increasingly resistant to drugs and insecticides.

To outpace rising resistance, the scientific community in the U.S. city of Seattle is developing innovations from data modelling and genetic modification to single-dose drugs and sugar traps.

Here are 10 facts about the deadly disease:

  • Some 3.2 billion people - almost half the world's population - are at risk of malaria.
  • In 2015, there were 214 million new cases reported in 95 countries, and 438,000 deaths.
  • Sub-Saharan Africa is the most affected region, home to 88 percent of cases and 90 percent of deaths last year.
  • Children under five years old, pregnant women and people living with HIV/AIDS are particularly vulnerable to malaria.
  • Since 2000, malaria death rates have fallen by 60 percent, and new cases have dropped by 37 percent.
  • In Africa, death rates dropped by two thirds, and by 71 percent among children under 5.
  • These advances came through widespread use of insecticide-treated bednets, indoor spraying, rapid diagnostic testing and artemisinin-based combination therapies over the past decade.
  • Mosquitoes are developing resistance to insecticides used to treat bednets and for indoor spraying. In Southeast Asia, the disease is becoming resistant to malaria drugs, and scientists are worried this resistance will spread to Africa in the future.
  • In January, WHO recommended large-scale pilot projects of a new vaccine in parts of Africa, which could pave the way for wider deployment.
  • The World Health Organization has targeted malaria for elimination in at least 35 countries by 2030, and reducing death rates by 90 percent. The U.N. Sustainable Development Goals have set a target of ending epidemic levels of malaria by 2030.
  • The Bill & Melinda Gates Foundation aims to eradicate malaria by 2040 and have called for a doubling of funding by 2025.
  • Global spending on malaria stands at $2.7 billion a year.
Image: WHO

Sources: World Health Organization, the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gates Foundation, Malaria No More

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Market failures cause antibiotic resistance. Here's how to address them

Katherine Klemperer and Anthony McDonnell

April 25, 2024

2:12

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum